Cargando…
Identifying Potential Tumor Antigens and Antigens-Related Subtypes in Hepatocellular Carcinoma for mRNA Vaccine Development
BACKGROUND: The mRNA vaccine has become a promising platform for cancer therapy. Lots of studies have been focusing on discovering novel potent cancer-associated antigens to develop mRNA vaccines against cancers. Besides, immunotyping shows the immune status, and immune microenvironment of immunotyp...
Autores principales: | Liao, Weiran, Shi, Zhitian, Tang, Haoren, Wu, Tiangen, Zhang, Cheng, He, Yutao, Zou, Renchao, Wang, Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444406/ https://www.ncbi.nlm.nih.gov/pubmed/36072981 http://dx.doi.org/10.1155/2022/6851026 |
Ejemplares similares
-
Identification of tumor antigens and immune subtypes of hepatocellular carcinoma for mRNA vaccine development
por: Lu, Tai-Liang, et al.
Publicado: (2023) -
Identifying tumor antigens and immuno‐subtyping in colon adenocarcinoma to facilitate the development of mRNA vaccine
por: Tan, Huaicheng, et al.
Publicado: (2022) -
Identification of tumor antigens and immune subtypes of cholangiocarcinoma for mRNA vaccine development
por: Huang, Xing, et al.
Publicado: (2021) -
Swertiamarin suppresses proliferation, migration, and invasion of hepatocellular carcinoma cells via negative regulation of FRAT1
por: Xiao, Shufeng, et al.
Publicado: (2020) -
Bioinformatics analysis of differentially expressed genes in hepatocellular carcinoma cells exposed to Swertiamarin
por: Tang, Haoran, et al.
Publicado: (2019)